Adjusting for Drug Wastage in Economic Evaluations of New Therapies for Hematologic Malignancies: A Systematic Review [CARE DELIVERY]
Conclusion:
Potential costs associated with drug wastage are considered in only one third of modern cost-effectiveness models. The impact of wastage on calculated ICERs and drug acquisition costs is potentially substantial. The modeling of wastage in base-case and sensitivity analyses is recommended for future economic evaluations of new intravenous therapies for hematologic malignancies. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Lien, K., Cheung, M. C., Chan, K. K. W. Tags: Pharmacoeconomics, Treatment related issues, Quality of care, Cost of care, Pharmacoeconomics, Financial resources, Leukemia, Lymphoma, Chemotherapy, Chemotherapy, Hematology CARE DELIVERY Source Type: research
Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits [CARE DELIVERY]
Conclusion:
BCOPs can contribute to a projected shortfall in needed patient visits for cancer treatment. BCOPs, along with nurse practitioners and physician assistants could substantially reduce, but likely not eliminate, the shortfall of providers needed for oncology patient visits. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Ignoffo, R., Knapp, K., Barnett, M., Barbour, S. Y., DAmato, S., Iacovelli, L., Knudsen, J., Koontz, S. E., Mancini, R., McBride, A., McCauley, D., Medina, P., O'Bryant, C. L., Scarpace, S., Stricker, S., Trovato, J. A. Tags: Caregiver, Access to care, Access to care, Quality of Care, Efficiency of Care, Pharmacy CARE DELIVERY Source Type: research
Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity [CARE DELIVERY]
Conclusion:
Despite the short duration, the NCCCP pilot resulted in an increase in the number of open trials as well as patient accrual at a faster rate than that observed nationally. These results, coupled with insights into the relative success of sites with varying sophistication at the outset, provide promise that lessons learned can be applied more broadly to increase research participation. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Hirsch, B. R., Locke, S. C., Abernethy, A. P. Tags: Methodology, Organization, Procedures, Clinical Trials CARE DELIVERY Source Type: research
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology [ASCO Special Article]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: American Society of Clinical Oncology Tags: Management and treatment, Policy, Survivorship, Information systems, Electronic health records, Quality of care, Affordable Care Act, Financing, Caregiver, Epidemiology, Family member, Access to care, Cost of care, Reimbursement, Financial resources, Gene Source Type: research
Ductal Carcinoma In Situ: To Irradiate or Not to Irradiate? [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Wong, J. S. Tags: Surgery, Radiation, Radiation Oncology, Radiation Oncology COMMENTARIES Source Type: research
Ductal Carcinoma In Situ: How Much Treatment Is Enough, How Much Is Too Much? [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Morrow, M. Tags: Surgery COMMENTARIES Source Type: research
Ductal Carcinoma In Situ of the Breast: Should Breast Irradiation Be Routinely Added to Surgical Excision? [Clinical Reviews]
Confusion exists among women with a new diagnosis of ductal carcinoma in situ and their physicians regarding choice of treatment. The press has accused the medical community of overtreatment and found many physicians eager to support or deny the charge. Improvements in treatment delivery have been matched with better definitions of risk on the basis of biology as defined by genomic analysis rather than only lesion size, margins, receptor status, and patient age. Understanding both the risk of a specific ductal carcinoma in situ progressing to invasive breast cancer and the risks of the treatment options allows tailored rec...
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Wood, W. C. Tags: Treatment related issues, Combined Modality, Adult Medical Oncology, Radiation Oncology, Surgical Oncology, Gene Expression and Profiling Clinical Reviews Source Type: research
Managing Erectile Dysfunction After Cancer: More Than Penile Rigidity [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Schover, L. R. Tags: Doctor-patient communication, Management and treatment, Complications of cancer and cancer treatment, Survivorship, Doctor-patient communication, Relationships & sexuality, Supportive care, Caregiver, Family member, Media, Patient, Survivor COMMENTARIES Source Type: research
Sexual Health After Cancer Therapy [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Higano, C. S., Zarowski, C., Wassersug, R., Elliott, S. Tags: COMMENTARIES Source Type: research
Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer [Clinical Reviews]
Cancer can cause sexual adverse effects by direct and indirect pathways. It can involve sexual organs, indirectly affect body image, or cause fatigue or depression with subsequent effects on libido. Erectile dysfunction (ED), the inability to obtain or maintain an erection firm enough for sexual intercourse, can also result from adverse effects of cancer treatment, such as fatigue, pain, or anxiety about therapy. In addition, depressed feelings about having cancer can affect sexuality, causing a range of signs and symptoms that can lead to ED. Chemotherapy, hormone therapy, surgery, and radiation can all cause sexual adver...
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Annam, K., Voznesensky, M., Kreder, K. J. Tags: Surgery, Radiation, Systemic Therapy Clinical Reviews Source Type: research
The Future of Myeloma Therapy: One Size Does Not Fit All [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Richardson, P. G. Tags: COMMENTARIES Source Type: research
Moving Toward a Tailored Therapy in Multiple Myeloma [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: DAgostino, M., Palumbo, A. Tags: Diagnosis & Staging, Chemotherapy, Combined Modality, Biology & Immunology, Translational Oncology COMMENTARIES Source Type: research
Myeloma Is Not a Single Disease [Clinical Reviews]
Treatment of plasma cell disorders has dramatically improved during the past decade as a result of the availability of new biology-based drugs, such as proteasome inhibitors and immunomodulatory agents. With increased attention to disease biology, however, it has become clear that there are many different subsets of patients with myeloma with different biologic drivers as well as different patient-based characteristics that can influence treatment. Obtaining initial genetics or genomics information can provide some of the information needed to define therapy after initial induction, and careful performance status assessmen...
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Lonial, S., Nooka, A. K. Tags: Management and treatment, Myeloma, Diagnosis & Staging, Chemotherapy, Biological Therapy, Biology & Immunology Clinical Reviews Source Type: research
Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era [Editorials]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Jain, N., Steensma, D., Stewart, D. J., Kantarjian, H. Tags: Affordable Care Act, Access to care, Access to care, Legislative issues, Access to care, Policy Analysis Editorials Source Type: research
Beta-Testing of Next-Generation DNA Sequencing for Patients With Advanced Cancers Treated at Community Hospitals [Editorials]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - April 11, 2016 Category: Cancer & Oncology Authors: Day, D., Bedard, P. L. Tags: Editorials Source Type: research
